FDA: ETHEX Recalls Dextroamphetamine Sulfate 5mg Tablets

ETHEX Corporation has recalled three lots of dextroamphetamine sulfate 5mg tablets which may contain oversized pills and up to twice the dose of the drug. ETHEX discovered a small number of oversized tablets in lots that had not yet been distributed.  While there have been no reports of oversized tablets from consumers, Ethex is recalling three lots of the drug as a precaution.

The round, orange tablets have ETHEX on one side and 311 on the other.  Lots being recalled are numbers 77946, 81141 and 81142.

Taking a higher than prescribed dose of dextroamphetamine might increase side effects of the drug including rapid heart rate, high blood pressure, tremors, decreased appetite  headache, insomnia, dizziness, blurred vision, stomach upset, or dry mouth.

ETHEX is not the only manufacturer or marketer of generic dextroamphetamine so you should check your tablets carefully to find out where they came from.

If you have questions about your medicine or side effects, talk to your doctor or your pharmacist.

You can also contact ETHEX Customer Service at 1-800-321-1705 or email  customer-service@ethex.com. Representatives available Monday through Friday, 8 am to 5 pm CST.

Bookmark and Share

This news article was originally posted on October 16th, 2008 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on October 16th, 2008
Tags: FDA, recalls

Comments

maria lurito

November 18, 2008 at 8:25pm

will this medication make my feet swell

Kate Murphy

November 19, 2008 at 7:46am

Swelling of the feet isn’t listed as an adverse effect of dextroamphetamine. If you are taking the drug and have swelling in your hands or feet, talk to your doctor about it.

In fact, talk to your doctor about swelling feet even if you are not taking dextroamphetamine so you can find out what the problem is.

What is more important is to check your tablets to be sure that they are not orange and marked with the word “ETHEX”. Both 5 mg and 10 mg have been recalled.

The recalled pills may include a double dose of dextroamphetamine and lead to rapid heart beat, high blood pressure, and an feeling of agitation and nervousness.

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe